Problems of variable biomarker evaluation in stratified medicine research—A case study of ERCC1 in non-small-cell lung cancer
2015; Elsevier BV; Volume: 92; Linguagem: Inglês
10.1016/j.lungcan.2015.11.017
ISSN1872-8332
AutoresK Malottki, Sanjay Popat, Jonathan J Deeks, Richard D. Riley, Andrew G. Nicholson, Lucinda Billingham,
Tópico(s)Genetic factors in colorectal cancer
ResumoConsistency of procedures for the evaluation of a predictive biomarker (including sample collection, processing, assay and scoring system) based on adequate evidence is necessary to implement research findings in clinical practice. As a case study we evaluated how a particular predictive biomarker, ERCC1, was assessed in research on platinum-based chemotherapy in non-small-cell lung cancer and what motivated the choice of procedure.
Referência(s)